Recent Articles
How Atypical PKCζ Regulates Path...
Roles of Serine/Threonine Phosph...
Histone Crotonylation: Reshaping...
Glycyllysine Modification: Master Regulator of Nuclear–ER Homeostasis
Concept Glycyllysine modification (K-ε-GV) is a newly identified, reversible post-translational modification (PTM) that regulates protein function via UFL1-UFBP1 complex–mediated conjugation. It acts as a critical molecular switch coordinating nuclear genome...
Glycyllysine Modification: Master Regulator of Nuclear–ER Homeostasis
Concept Glycyllysine modification (K-ε-GV) is a newly identified, reversible post-translational modification (PTM) that regulates protein function via UFL1-UFBP1 complex–mediated conjugation. It acts as a critical molecular switch coordinating nuclear genome...
Read More
Dead Cell Removal Sorting: A Key Strategy to Enhance Experimental Data Reliab...
Concept In cellrelated experiments, dead cells are frequently generated during cell culture, tissue dissociation, cryopreservation, and thawing. These nonviable cells release intracellular components such as proteases, nucleases, and reactive oxygen...
Dead Cell Removal Sorting: A Key Strategy to Enhance Experimental Data Reliab...
Concept In cellrelated experiments, dead cells are frequently generated during cell culture, tissue dissociation, cryopreservation, and thawing. These nonviable cells release intracellular components such as proteases, nucleases, and reactive oxygen...
Read More
PTEN Companion Diagnostic Antibodies Direct Precision Cancer Therapy
1. Literature Information This review establishes PTEN as a key tumor suppressor and demonstrates that PTEN IHC is a reliable companion diagnostic to predict PI3K/AKT/mTOR inhibitor response and immunotherapy efficacy....
PTEN Companion Diagnostic Antibodies Direct Precision Cancer Therapy
1. Literature Information This review establishes PTEN as a key tumor suppressor and demonstrates that PTEN IHC is a reliable companion diagnostic to predict PI3K/AKT/mTOR inhibitor response and immunotherapy efficacy....
Read More
FRα Antibody Guides Targeted Therapy Decisions for Ovarian Cancer
1. Literature Information This research highlights FRα as a pivotal target in ovarian cancer and validates FRα antibodybased IHC as a critical tool to select patients for FRαtargeted ADC therapy....
FRα Antibody Guides Targeted Therapy Decisions for Ovarian Cancer
1. Literature Information This research highlights FRα as a pivotal target in ovarian cancer and validates FRα antibodybased IHC as a critical tool to select patients for FRαtargeted ADC therapy....
Read More
FRα Companion Diagnostic Antibody Guides Precision ADC Therapy
1. Literature Information This study establishes FRα (FOLR1) as a validated biomarker for ADC therapy and demonstrates that FRα IHC is a clinically approved companion diagnostic to identify eligible patients....
FRα Companion Diagnostic Antibody Guides Precision ADC Therapy
1. Literature Information This study establishes FRα (FOLR1) as a validated biomarker for ADC therapy and demonstrates that FRα IHC is a clinically approved companion diagnostic to identify eligible patients....
Read More
Nectin-4 Antibody: A Rising Star in Solid Tumor Targeted Therapy
1. Literature Information This review summarizes Nectin4 as a leading target for ADCs and emphasizes the essential role of Nectin4 antibodies in patient selection across bladder, breast, ovarian, lung, and...
Nectin-4 Antibody: A Rising Star in Solid Tumor Targeted Therapy
1. Literature Information This review summarizes Nectin4 as a leading target for ADCs and emphasizes the essential role of Nectin4 antibodies in patient selection across bladder, breast, ovarian, lung, and...
Read More